Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders

Jessica Zammit; Vladimir Ferrafiat

doi:10.1017/S1092852922001110

Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders

CNS Spectr. 2023 Oct;28(5):530-533. doi: 10.1017/S1092852922001110. Epub 2022 Nov 18.

Authors

Jessica Zammit¹, Vladimir Ferrafiat^{2

3

4}

Affiliations

¹ Department of Child and Adolescent Psychiatry, URHEA, CH Le Rouvray, Sotteville les Rouen, France.
² Reference Center for Inborn Errors of Metabolism, La Timone University Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France.
³ Reference Center for Intellectual Disabilities of Rare Causes, La Timone University Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France.
⁴ Pediatric Neurology, La Timone University Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France.

PMID: 36398402
DOI: 10.1017/S1092852922001110

No abstract available

Keywords: anxiety; clonidine; hyperactivity; impulsivity; intellectual disability; irritability; neurodevelopmental disorder; psychomotor instability.

Publication types

Letter

MeSH terms

Adolescent
Attention Deficit Disorder with Hyperactivity*
Autism Spectrum Disorder*
Clonidine / therapeutic use
Humans
Inpatients
Intellectual Disability* / drug therapy
Neurodevelopmental Disorders* / drug therapy

Substances

Clonidine